| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.031 | 0.5 |